The Presence of m1 to m5 Receptors in Human Sclera: Evidence of the Sclera as a Potential Site of Action for Muscarinic Receptor Antagonists
- 1 January 2006
- journal article
- research article
- Published by Informa UK Limited in Current Eye Research
- Vol. 31 (7-8), 587-597
- https://doi.org/10.1080/02713680600770609
Abstract
Purpose: The aim of this study was to identify the presence of muscarinic acetylcholine receptors (mAChRs) in human sclera in order to determine whether the sclera is a potential site of action for mAChR antagonists. Methods: Cell lines of human scleral fibroblasts were cultured in Dulbecco modified Ealge's medium. Reverse transcription–polymerase chain reaction (RT-PCR) and Northern blot analysis were used to detect mRNA expression of muscarinic acetylcholine receptors in the cell lines of the fibroblasts. Western blot analysis and immunocytochemistry were used to detect proteins of mAChRs in the cell lines. Immunohistochemical study was used to further detect the presence of mAChR proteins in the frozen scleral sections. Results: The cultured fibroblasts demonstrated mRNA expression of five mAChRs (m1 to m5) in RT-PCR and Northern blot analysis. The molecular size of mRNA expression was largest for the m3 receptor, followed by the m2, m4, m5, and m1 in both RT-PCR and Northern blot analysis. Proteins of the m1 to m5 receptors were present in cell line fibroblasts under Western blot analysis and immunocytochemistry with a range of molecular weight from 80 kDa (m5) to 60 kDa (m1) in Western blot analysis. The presence of these five receptors was also detected in scleral tissues with immunohistochemistry. Conclusions: This study demonstrated the presence of mAChR subtypes (m1 to m5) in human scleral fibroblasts at both mRNA and protein levels. This finding indicates that the sclera is a potential site of action for the currently used mAChR antagonists in prevention of human myopia.Keywords
This publication has 26 references indexed in Scilit:
- Interventions to retard myopia progressionOphthalmology, 2003
- Role of the sclera in the development and pathological complications of myopiaProgress in Retinal and Eye Research, 2003
- Role of the non-neuronal cholinergic system in the eye: A reviewLife Sciences, 2003
- Molecular Aspects of Muscarinic Receptor DimerizationNeuropsychopharmacology, 2000
- Modulation of Scleral DNA Synthesis in Development of and Recovery from Induced Axial Myopia in the Tree ShrewExperimental Eye Research, 1999
- Identification and Mapping of Keratinocyte Muscarinic Acetylcholine Receptor Subtypes in Human Epidermis11Presented at the 17th International Congress of Biochemistry and Molecular Biology in conjunction with the Annual Meeting of the American Society for Biochemistry and Molecular Biology, San Francisco, California, August 25 1997, and at the Third Tricontinental Meeting of the Society for Investigative Dermatology, the European Society for Dermatological Research and the Japanese Society for Investigative Dermatology, Cologne, Germany, May 9 1998, and published in the form of an abstract in the Faseb Journal 11:A1057 1997 and Journal of Investigative Dermatology 110:579 1998, respectively.Journal of Investigative Dermatology, 1998
- Distribution of muscarinic cholinergic receptor proteins m1 to m4 in area 17 of normal and monocularly deprived rhesus monkeysJournal of Comparative Neurology, 1997
- Keratinocyte Muscarinic Acetylcholine Receptors: Immunolocalization and Partial CharacterizationJournal of Investigative Dermatology, 1995
- Nature and nurture of myopiaNature, 1994
- Regulation of Neuronal Muscarinic Acetylcholine Receptor Number by Protein GlycosylationJournal of Neurochemistry, 1986